Literature DB >> 19651573

Medication use among children <12 years of age in the United States: results from the Slone Survey.

Louis Vernacchio1, Judith P Kelly, David W Kaufman, Allen A Mitchell.   

Abstract

OBJECTIVES: Using data from the Slone Survey, we sought to define the prevalence of over-the-counter and prescription medication use among US children <12 years of age and to determine the prevalence and patterns of use of the most commonly used medications.
METHODS: The Slone Survey was a random-digit-dial telephone survey of medication use in the previous 7 days for a representative sample of the US population. Between February 1998 and April 2007, we enrolled 2857 children 0 to 11 years of age from the 48 contiguous US states.
RESULTS: The survey response rate was 61%. Overall, 56% of children had used >or=1 medication product in the 7 days preceding the interview, with 15%, 7.1%, 3.1%, and 1.9% taking 2, 3, 4, and >or=5 medications, respectively, during that time period. Twenty percent of children took >or=1 prescription-only medications, but <6% used >or=2 prescription-only drugs within a given week. Fewer than 0.5% of children were reported to have used any particular herbal product. The most commonly used over-the-counter medication products were acetaminophen alone, multivitamins, and ibuprofen alone. The most commonly used prescription-only medications across all age groups were amoxicillin, albuterol, and multivitamins with fluoride. The most commonly consumed active ingredients (excluding vitamins) were acetaminophen, iron, ibuprofen, and various cough/cold ingredients (pseudoephedrine, dextromethorphan, and various first-generation antihistamines).
CONCLUSIONS: The majority of US children <12 years of age use >or=1 medication product in a given week. The preponderance of pediatric medication exposure involves over-the-counter products.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651573     DOI: 10.1542/peds.2008-2869

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  44 in total

1.  Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.

Authors:  Kristina Star; G Niklas Norén; Karin Nordin; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 2.  Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases.

Authors:  Kennon Heard; Alison Bui; Sara L Mlynarchek; Jody L Green; G Randall Bond; Richard F Clark; Eran Kozer; Raymond S Koff; Richard C Dart
Journal:  Am J Ther       Date:  2014 May-Jun       Impact factor: 2.688

3.  Liquid medication dosing errors in children: role of provider counseling strategies.

Authors:  H Shonna Yin; Benard P Dreyer; Hannah A Moreira; Linda van Schaick; Luis Rodriguez; Susanne Boettger; Alan L Mendelsohn
Journal:  Acad Pediatr       Date:  2014 May-Jun       Impact factor: 3.107

Review 4.  Honey for treatment of cough in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-12       Impact factor: 3.275

5.  Cost Implications of Escalating Intravenous Acetaminophen Use in Children.

Authors:  Florence T Bourgeois; Dionne A Graham; Aaron S Kesselheim; Adrienne G Randolph
Journal:  JAMA Pediatr       Date:  2019-05-01       Impact factor: 16.193

Review 6.  Impact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic review.

Authors:  Meghann E Kyle; James C Wang; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2015-01-05       Impact factor: 3.497

7.  Treating cough and cold: Guidance for caregivers of children and youth.

Authors:  Ran D Goldman
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

8.  Urinary paracetamol and time-to-pregnancy.

Authors:  Melissa M Smarr; Katherine L Grantz; Rajeshwari Sundaram; José M Maisog; Masato Honda; Kurunthachalam Kannan; Germaine M Buck Louis
Journal:  Hum Reprod       Date:  2016-07-13       Impact factor: 6.918

9.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

10.  Can increases in CHIP copayments reduce program expenditures on prescription drugs?

Authors:  Bisakha Sen; Justin Blackburn; Michael Morrisey; David Becker; Meredith Kilgore; Cathy Caldwell; Nir Menachemi
Journal:  Medicare Medicaid Res Rev       Date:  2014-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.